Communication and Medication Support for Lupus
Intervention to Improve Communication and Medication Adherence in Lupus
Recruiting
N/A
Interventional Study
Systemic Lupus Erythematosus
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 480 (estimated)
- Sponsor
- Duke University · Other
Who this trial is looking for
This trial is looking for adults with Lupus to help improve how patients and doctors communicate about medications. Participants will work with healthcare providers to better understand and overcome challenges with taking their medications.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 18 years or older
- I speak English and can give consent
- I have been diagnosed with systemic lupus erythematosus
- I am receiving care from doctors involved in this trial
- I am prescribed at least one medication for lupus
- I fill my lupus medications at a pharmacy that is linked to Surescripts
You may not be able to join if
- I do not speak English
- I am prescribed only corticosteroids for lupus
- I have someone with me who cannot stay in the waiting room during my visit
- I do not wish to be audio recorded
- I am a minor without a parent or legal guardian
- I am unable to give consent
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
CO-LEAD is an intervention to improve patient-provider communication and medication adherence among patients with systemic lupus erythematosus (SLE).
The purpose of this study is to optimize the culturally appropriate delivery and test the effect of the CO-LEAD intervention, which includes the following:
1. clinicians will be provided with a program to teach them to use effective communication s…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Clinician Inclusion Criteria:
1. Adult rheumatology attendings, advanced practice providers, and fellows at the two academic institutions
2. Clinicians who have ambulatory rheumatology care at least ½ day per week
Clinician Exclusion Criteria:
1. Clinicians at Duke University who were involved in…
Contacts